Pay in 4 interest-free payments of $5.82 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
The goal is to stabilize
This makes the standalone approach more economical for most patients
Though early work from companies like Vertex (Semma Tx acquisition) are focused on regeneration of pancreatic islets (for diabetes), Novo Nordisk recently inked a deal (including $75M upfront) with early-stage cell therapy player Aspect Biosystems
US launch In the US, in the first week of its launch in January 18,000 prescriptions were signed off, and two million more since then
Retatrutide is an investigational triple agonist that is not yet FDA approved, and you should be cautious of anyone selling it online today
US$ 21.63
:format(webp))
US$ 25.57
US$ 24.07
US$ 29.30
